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Murine Ksr interacts with MEK and inhibits Ras-induced
transformation
A. Denouel-Galy*, E.M. Douville†, P.H. Warne†, C. Papin*, D. Laugier*, 
G. Calothy*, J. Downward† and A. Eychène*
Background: Ksr (kinase supressor of Ras) was identified as a regulator of the
Ras–MAP kinase (mitogen-activated protein kinase) pathway by genetic
screens in Drosophila and Caenorhabditis elegans. Ksr is a kinase with
similarities to the three conserved regions of Raf kinases, especially within the
kinase domain. To investigate whether these structural similarities correlated
with common functional properties, we examined the ability of mKsr-1, the
murine homolog of Ksr, to interact with components of the vertebrate MAP
kinase pathway.
Results: In the yeast two-hybrid interaction assay, mKsr-1 did not bind to
either Ras, B-Raf or Raf-1, but interacted strongly with both MEK-1 and MEK-2,
activators of MAP kinase. The Ksr–MEK interaction was confirmed by
co-immunoprecipitation experiments. Ectopically expressed mKsr-1
co-precipitated with endogenous MEK-1 in COS-1 cells, and endogenous Ksr
and MEK co-precipitated from PC12 cells. Phosphorylation of MEK by mKsr-1
was not detected, however. In contrast, the MEK subpopulation complexed
with mKsr-1 in COS-1 cells or PC12 cells did not display kinase activity. This
ability of Ksr to block MEK in an inactive form correlated with a biological
response: mKsr-1 did not transform NIH3T3 cells, and, furthermore, mKsr-1
reduced Ras-induced transformation. Similarly, mKsr-1 inhibited the
proliferation of embryonic neuroretina cells induced by Ras and B-Raf but not
that induced by MEK.
Conclusions: Our results suggest a novel mechanism for Ksr in regulating the
MAP kinase pathway, at least in part through an ability to interact with MEK.
Background
Mitogen-activated protein kinase (MAP kinase) cascades
are signaling pathways involved in several physiological
processes, and have been conserved from yeast to verte-
brates [1,2]. In metazoans, the Ras oncoprotein mediates a
MAP kinase cascade following its activation by extra-
cellular mitogenic or differentiating signals. In this
cascade, proteins of the Raf family function as MAP
kinase kinase kinases (MAPKKK). Raf proteins have been
shown to phosphorylate and activate MAPKKs (MAP
kinase kinases) called MEKs (MAP kinase or ERK
kinases), which in turn phosphorylate and activate MAP
kinases, which are also called ERKs (extracellular signal-
regulated kinases). In Caenorhabditis elegans, this cascade
controls vulval induction and other developmental events,
and involves the let-60 (Ras family), lin-45 (Raf), mek-2
(MEK) and sur-1 (MAP kinase) genes [3,4]. In Drosophila,
this cascade, involving the Ras1, Draf, Dsor1 (MEK) and
rolled (MAP kinase) genes, controls the determination
of cell fate at embryonic termini, and controls neuronal
differentiation of R7 photoreceptor cells (the Sevenless
pathway) in the compound eye [5–7]. In vertebrates, the
Raf–MEK–ERK cascade displays a higher degree of com-
plexity: two ERKs, ERK-1 and ERK-2 [8], two MEKs,
MEK-1 and MEK-2 [9–12] and three Raf proteins, A-Raf,
B-Raf and c-Raf-1 [13–15] have been characterized so far.
In addition to this diversity, other components also con-
tribute to the regulation of the cascade, including dephos-
phorylation [16–18] and feedback controls [19].
A novel protein kinase, Ksr (kinase supressor of Ras),
identified by genetic screens in both C. elegans and
Drosophila, has also been shown to regulate the MAP
kinase pathway [20–22]. Specifically, loss-of-function ksr
alleles block the effects of ras gain-of-function mutations
in both the Drosophila Sevenless and C. elegans vulval
induction pathways, but they have no effect on these
pathways in otherwise wild-type animals. In addition, the
ksr loss-of-function mutations are recessively lethal in
Drosophila, whereas they have a lethal effect only in a
small percentage of larvae in C. elegans. 
Ksr appears to be evolutionarily conserved: mammalian
homologs, mKsr-1 and hKsr-1, have been isolated from
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mice and humans, respectively [20]. In agreement with
the genetic observations in Drosophila and C. elegans,
mKsr-1 was found to cooperate with activated Ras to
promote Xenopus oocyte maturation [23,24]. Although
several recent reports showed that mKsr-1 and Raf-1 can
form membrane-bound complexes, the experiments did
not support the possibility of a direct interaction between
the two proteins, but rather suggested the requirement for
an intermediate molecule [23–25]. Furthermore, experi-
ments assessing the ability of mKsr-1 to phosphorylate
and/or activate Raf-1 had contradictory results.
Interestingly, the Raf family kinases are the closest rela-
tives to Ksr; the sequence of the kinase domain of mKsr-1
is 35.1% and 33.7% identical to those of B-Raf and Raf-1,
respectively. In addition, mKsr-1 shares other structural
similarities with Raf kinases, including a cysteine-rich
motif (CA3 domain) which is present in the CR1 domain
of Raf, and a serine/threonine-rich sequence (CA4) that
resembles the CR2 of Raf [20]. Because of these structural
similarities, and in the absence of a precise mechanistic
understanding of how Ksr regulates the MAP kinase
pathway, the possibility that Ksr may act in parallel to Raf
kinases cannot be ruled out.
To further address this issue, we have investigated the
relationship between mKsr-1 and different components of
the Ras–MAPK pathway in vertebrates. We show that
mKsr-1, like Raf-1 and B-Raf, interacts directly with
MEK. No MEK phosphorylation is seen as a result, and
MEK autophosphorylation activity is blocked. Accord-
ingly, mKsr-1 reduced NIH3T3 cell transformation
induced by Ras. In addition, overexpression of mKsr-1 sig-
nificantly inhibited Ras- and B-Raf-induced proliferation
of chicken embryonic neuroretina (NR) cells. In contrast,
overexpression of mKsr-1 was not sufficient to abolish NR
cell proliferation induced by a constitutively activated
MEK-1 protein, consistent with a mechanism of action
at the level of MEK. Taken together, our results raise
the possibility that Ksr could regulate the MAP
kinase pathway by a previously unidentified mechanism
involving the formation of Ksr–MEK complexes.
Results
Interaction of mKsr-1 with MEK
To investigate the role of Ksr in the regulation of the
vertebrate MAP kinase cascade, we tested its ability to
interact with different components of this pathway.
Various fragments of mKsr-1, the murine homolog of ksr
[20], were subcloned in-frame with GAL4 sequences in
yeast two-hybrid vectors, and the proteins were tested for
their ability to interact with constitutively activated Ras
(RasV12), Raf-1, B-Raf, MEK-1 or MEK-2. Constructs
encoding recombinant proteins were co-transfected into
the yeast strain Hf7c containing the HIS3 and lacZ
reporter genes. Transformants were tested for their ability
to grow in the absence of histidine and for β-galactosidase
activity. The results presented in Figure 1 show that
mKsr-1 did not bind directly to Raf-1, B-Raf or Ras. In
contrast, we detected significant interaction between
mKsr-1 and both mammalian MEK-1 and MEK-2
(Figure 1b). The affinity of this interaction appeared to be
weak (expressed as a His+/LacZ– phenotype, Figure 1b)
when tested with full-length mKsr-1, but steadily
increased as amino-terminal sequences were deleted from
the protein. Specifically, a region of mKsr-1 restricted to
the kinase domain (Ksr CA5, Figure 1a) strongly inter-
acted with MEKs; the binding affinity was lower than that
observed with B-Raf, but higher than that found with Raf-
1. Thus, as observed with Raf–MEK interactions, the
binding of Ksr to MEK was mediated through its kinase
domain. In confirmation of this, an amino-terminal moiety
of mKsr-1 lacking the CA5 domain did not bind to MEK
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Figure 1
Murine Ksr interacts with mammalian MEK-1 and MEK-2 in the yeast
two-hybrid system. (a) Schematic representation of the various
portions of mKsr-1 tested in the two-hybrid system. The CA1, CA2,
CA3, CA4 and CA5 conserved regions of Ksr proteins are indicated in
blue boxes. CA3 contains a cysteine-rich motif (C) and CA4 contains a
serine/threonine-rich motif (S/T). Amino-acid residue numbers of each
construct are indicated. (b) The two-hybrid system was used to
determine interactions between the constructs depicted in (a), and
either hamster MEK-1, mouse MEK-2, human Raf-1, quail B-Raf or
human Ha-RasV12 [32]. HIS3 expression levels (His) and the
qualitative β-galactosidase activity (LacZ) are indicated. For HIS3
expression, + indicates His+ colonies observed within 2 days and –
indicates no growth in the absence of histidine. For β-galactosidase
activity, ++++ indicates a very strong interaction (blue color
development within 1 h), ++ a strong interaction (blue color
development within 2 h), + an intermediate interaction (blue color
development after 6 h), – no blue color development. Weak
interactions are indicated by His+/LacZ– transformants. His–/LacZ–
indicates an absence of interaction. All the interactions were tested in
both orientations for each pair of proteins, with identical results. 
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(data not shown). In addition, the Ksr–MEK interaction
appears to be highly specific, because mKsr-1, like Raf-1
and B-Raf, did not interact with the distantly related MAP
kinase kinases MKK-3 and MKK-4 [26] in the two-hybrid
system (data not shown).
To confirm the Ksr–MEK interaction using another
experimental approach, we raised specific antibodies
against the carboxyl terminus of mKsr-1 and performed
co-immunoprecipitation experiments. COS-1 cells were
transfected with a plasmid encoding full-length mKsr-1
(pSVL/mKsr-1) and cell lysates were immunoprecipitated
with either anti-mKsr-1 or anti-MEK-1 specific antisera.
Immunoprecipitates were resolved by SDS–PAGE and
western blotting was used to visualize mKsr-1 and MEK-
1. Ectopically expressed mKsr-1 migrated as a doublet of
108–115 kDa, which was not detectable in cells trans-
fected with the control vector or in untransfected cells
(Figure 2). Western blotting with anti-MEK-1 revealed
the presence of MEK in the mKsr-1 immunoprecipitates
(Figure 2a). This co-immunoprecipitation was also
observed in COS-1 cells expressing MEK-1 protein
tagged with hemagglutinin (HA1), using an anti-HA1
monoclonal antibody for western blotting (Figure 2b).
Furthermore, we found that mKsr-1 could be co-immuno-
precipitated with endogenous MEK-1, using an anti-
MEK-1 antiserum (Figure 2a). We also found that
full-length mKsr-1 associated with MEK-1 in vitro. As
shown in Figure 2c, mKsr-1 translated in rabbit reticulo-
cyte lysate interacted with immobilized GST–MEK-1
fusion protein but not with GST protein alone, confirming
that the Ksr–MEK interaction is direct. We also investi-
gated the existence of Ksr–MEK complexes in a cell
system in which neither protein was overexpressed. We
found that Ksr was expressed at detectable levels in PC12
cells and that endogenous MEK could be detected in
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Figure 2
Association of mKsr-1 and MEK-1 in COS-1
cells and in vitro. (a) COS-1 cells were
transfected with pSVL (lane 1), pSVL/mKsr-1
(lane 2) or were not transfected (lane 3), and
protein expression was analyzed 48 h later.
Cell lysates were immunoprecipitated with
either anti-MEK-1 or anti-mKsr-1 polyclonal
antibodies as indicated (IP) and immune
complexes were resolved on SDS–PAGE for
western blotting analysis. MEK-1
immunoprecipitates were first analyzed by
immunoblotting with the anti-mKsr-1
antibody. After stripping, the membrane was
then immunoblotted with the anti-MEK-1
antibody. Ksr immunoprecipitates were first
analyzed by immunoblotting with the anti-
MEK-1 antibody. After stripping, the
membrane was then immunoblotted with the
anti-mKsr-1 antibody. The positions of MEK-1
and mKsr-1 are indicated by arrows. (b)
COS-1 cells were co-transfected with
pECE/HA–MEK-1 and pSVL/mKsr-1 (lanes
1,2,3) or were not transfected (lane 4), and
protein expression was analyzed 48 h later.
Cell lysates were immunoprecipitated with
either anti-HA-epitope (lanes 1,4) or anti-
mKsr-1 (lane 2) antibodies as indicated (IP1).
The supernatant of the mKsr-1
immunoprecipitation was then
immunoprecipitated with the anti-HA-epitope
antibody (lane 3) as indicated (IP2). Immune
complexes were resolved by SDS–PAGE and
immunoblotted with the anti-HA-epitope
monoclonal antibody. (c) Association of
mKsr-1 with MEK-1 in vitro. The pBKS(–)
plasmid encoding the full-length mKsr-1 was
translated in rabbit reticulocyte lysate in the
presence of [35S]methionine. Translated
proteins (20 µl) were incubated with
immobilized GST–MEK-1 fusion protein
(lane 3) or GST alone (lane 2) and, after
extensive washing, bound proteins were
eluted in gel sample buffer and analyzed by
SDS–PAGE. Translated proteins (5 µl) were
directly loaded on the gel as a control
(lane 1). The identification of the mKsr-1
bands was confirmed by immunoblotting with
the anti-mKsr-1 antibody (data not shown).
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mKsr-1 immunoprecipitates from PC12 cell lysates, sug-
gesting that the Ksr–MEK interaction takes place under
physiological conditions (Figure 3).
The MEK fraction complexed with Ksr is inactive
Because Ksr and Raf proteins have structural similarities
and share the ability to interact directly with MEK, we
considered the possibility that mKsr-1 could regulate the
MAP kinase pathway by directly activating MEK. We
repeatedly failed to detect phosphorylation of MEK by Ksr
using different sources of MEK as substrates, however,
including immunoprecipitated or GST-fusion proteins
(data not shown). On the contrary, the binding of MEK
and Ksr appeared to inhibit the autophosphorylation activ-
ity of MEK. Thus, we could not detect phosphorylation of
the MEK subpopulation complexed with endogenous Ksr
in PC12 cells, even after treating the cells with epidermal
growth factor (EGF) or nerve growth factor (NGF;
Figure 3b). However, given that relatively little MEK pre-
cipitated with Ksr antibodies, it is difficult to draw conclu-
sions about MEK activity from these experiments. We
therefore investigated MEK activity in COS-1 cells overex-
pressing mKsr-1 at levels sufficiently elevated to allow
detection of significant amounts of MEK immunoprecipi-
tated with Ksr antibodies. Results presented in Figure 4
indicate that the MEK subpopulation complexed with
mKsr-1 in COS-1 cells could not be detected in an in vitro
kinase assay (Figure 4, lane 2), suggesting that MEK is not
phosphorylated by Ksr and does not display kinase activity.
In contrast, MEK-1 immunoprecipitated directly or from
the supernatant of mKsr-1 immunoprecipitation under-
went autophosphorylation (Figure 4, lanes 1,3).
Specific inhibition by mKsr-1 of Ras-induced NIH3T3 cell
transformation 
Because the interaction of MEK with mKsr-1 appeared to
block MEK in an inactive state, we investigated the conse-
quence of mKsr-1 expression on fibroblast transformation
induced by Ras, which normally requires MEK activity.
Transformation by activated Ras has been shown to
involve distinct signaling pathways [27,28] mediated by at
least four different effectors: Raf-1 [29,30], B-Raf [31,32],
Ral guanine nucleotide dissociation stimulator (Ral-GDS)
[33–36] and the catalytic subunit of phosphatidylinositol-
3-OH kinase (PI 3-kinase) [37,38] have all been reported
to interact directly with Ras in vertebrates. In addition,
indirect activation of Rac and Rho has been shown to con-
tribute to the morphological transformation of cells
induced by Ras [39–41]. We examined the effect of mKsr-
1 expression on NIH3T3 cell transformation induced by
activated versions of Ras, Rac, Rho and Ral. Plasmids
encoding each protein were transfected into NIH3T3
cells, either alone or in combination with mKsr-1, and
focus formation assays were caried out over 2 weeks. 
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Figure 3
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MEK-1and MEK-2 co-precipitate with Ksr-1 from PC12 cells. 
(a) Lysates from PC12 cells which had been left unstimulated (–) or
stimulated (+) with EGF for 2 min were immunoprecipitated with either
anti-MEK-1/2, anti-mKsr-1 or Ksr pre-immune sera in the presence (+)
or absence (–) of competing Ksr immunizing peptide. The
corresponding immunoprecipitates were assayed for the presence of
MEK-1/2 and Ksr-1 by western blotting. The relative positions of MEK
and Ksr-1 are indicated by arrows. IP indicates immunoprecipitation.
(b) PC12 cells were either left unstimulated, stimulated with EGF for
2 min or with NGF for 5 min and cell lysates were immunoprecipitated
with either anti-MEK-1/2 or anti-mKsr-1 polyclonal antibodies.
Immunoprecipitates were subjected to an in vitro kinase assay (b) and
the corresponding immunoprecipitates assayed for the levels of 
MEK-1/2 and Ksr-1 by western blotting (c).
Expression of full-length mKsr-1 alone did not lead to cell
transformation (Figure 5). Interestingly, the number of
transformed foci was reproducibly reduced by about 60%
in fibroblasts co-transfected with both RasV12 and
mKsr-1, compared to control cells. In contrast, co-transfec-
tion of mKsr-1 had no significant effect on transformation
induced by activated Rac (RacV12) or activated Rho
(RhoV14). Finally, we did not observe a significant
cooperative effect when activated Ral (RalL72), which is
not transforming by itself, was co-transfected with mKsr-1.
In these experiments, we used only 5 ng of RasV12
plasmid, compared to 500 ng for the other constructs,
because of the higher transformation efficiency of Ras;
transfection assays using 500 ng of RasV12 plasmid fol-
lowed by appropriate cell dilutions led to similar results,
however (data not shown). To confirm that mKsr-1 was
not able to cooperate with Ras in cell transformation, we
also investigated the effect of mKsr-1 in co-transfection
assays with three different RasV12 mutants that differ in
their ability to bind to Ras effectors. Each mutant was pre-
viously shown to bind to only one of the three direct Ras
effectors: RasS35 binds only to Raf, RasG37 to Ral-GDS
and RasC40 to the p110 catalytic subunit of PI 3-kinase
[28]. None of these mutants is able to transform cells
when expressed alone, but RasG37 and RasC40 can syner-
gize with Raf-1, and RasS35 and RasG37 with PI 3-kinase,
to induce transformation [28]. We found that co-transfec-
tion of mKsr-1 with any of these mutants did not result in
significant transformation of NIH3T3 cells (Figure 5).
Taken together, these results confirm that mKsr-1 does
not cooperate with Ras for fibroblast transformation. 
Inhibition by mKsr-1 of the proliferation of neuroretina
cells induced by Raf or Ras but not that induced by MEK
Because our observation that mKsr-1 inhibited Ras-
induced fibroblast transformation appeared to contradict
previous studies reporting cooperative effects of Ras and
Ksr in other biological systems, we investigated whether
the inhibitory effect of mKsr-1 on the Ras–MAPK
pathway could be observed in another cell type. We
have previously reported that constitutive activation of
Raf-1 and B-Raf was sufficient to induce sustained pro-
liferation of chicken embryonic NR cells, which are nor-
mally quiescent in culture [42,43]. We used this cell
system to test the effect of mKsr-1 overexpression on
cell proliferation induced by activators of the MAP
kinase pathway. NR cultures were infected with either
C11, IC11 or RCAS/MEKDD avian retroviruses, which
express v-Ha-Ras [44], v-Rmil (an activated version of
the avian homolog of B-Raf) [43], and a constitutively
activated MEK-1 protein in which serine residues 218
and 222 are substituted by aspartic acid residues [45],
respectively. It is noteworthy that the growth rate of NR
cells infected with C11 and RCAS/MEKDD viruses was
higher than that of the IC11-infected cells (data not
shown). Exponentially growing infected cultures were
then transfected with either pRcRSV/mKsr-1 or empty
pRcRSV plasmids. Focus formation by proliferating NR
cells was examined after selection for neomycin-resistant
cells. Overexpression of mKsr-1 markedly decreased
both the number and the size of foci of proliferating NR
cells in C11- and IC11-infected cultures, compared to
cultures transfected with the pRcRSV empty vector
(Figure 6). This effect appeared more pronounced in
C11- than in IC11-infected NR cells, suggesting that
mKsr-1 competes more efficiently with endogenous Raf
proteins in C11-infected cells than with overexpressed
and constitutively activated B-Raf protein in IC11-
infected cells, for the binding to MEK. In contrast, over-
expression of mKsr-1 did not significantly decrease the
number of foci of proliferating cells in RCAS/MEKDD-
infected NR cultures, although the size of the foci
appeared to be reduced.
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Figure 4
MEK-1 complexed with mKsr-1 in COS-1 cells is not phosphorylated.
COS-1 cells were transfected with pSVL/mKsr-1 and protein
expression was analyzed 48 h later. Cell lysates were
immunoprecipitated with either anti-MEK-1 (reaction 1) or anti-mKsr-1
(reactions 2,3) polyclonal antibodies as indicated (IP1). The
supernatant of the mKsr-1 immunoprecipitation was then
immunoprecipitated with the anti-MEK-1 antibody (reaction 3) as
indicated (IP2). Immunoprecipitates from 1, 2 and 3 were subjected to
an in vitro kinase assay, separated by SDS–PAGE and transferred to
Immobilon-P membranes. Membranes were then autoradiographed
(indicated by Kinase) before successive western blotting analysis
using the anti-mKsr-1 antibody followed by the anti-MEK-1 antibody.
Note that eight times less material was loaded in lanes 1 and 3 than in
2, in order to adjust the immunoprecipitated levels of MEK-1. The
positions of MEK-1, mKsr-1 and the immunoglobulins (Ig) are indicated
by arrows.
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Discussion
Ksr was identified as a positive regulator of the Ras–MAP
kinase pathway by genetic screens in Drosophila and C.
elegans. Recent reports have indicated that the murine
homolog of Ksr, mKsr-1, positively regulates the MAP
kinase pathway in vertebrates, as it is able to cooperate
with Ras during Xenopus oocyte maturation. The precise
mechanism of mKsr-1 action remains unclear, however
[23–25]. In this study, we investigated the possible inter-
action of mKsr-1 with different components of the verte-
brate Ras–MAP kinase pathway. Our results demonstrate
that mKsr-1 does not bind to mammalian RasV12, in
agreement with previous reports that the Drosophila and C.
elegans homologs of Ras did not interact with Ksr in the
two-hybrid system [20,22]. Although the CA3 domain of
mKsr-1 contains a cysteine-rich motif similar to the one in
Raf that is involved in increasing the affinity of the
Raf–Ras interaction [46], mKsr-1 lacks the minimal Ras-
binding domain of Raf proteins that is located upstream of
the cysteine-rich motif in the CR1 domain [47].
We also found that mKsr-1 did not bind directly to Raf-1
or to B-Raf in the two-hybrid system. This observation
strengthens the possibility that the interaction observed
between Raf-1 and mKsr-1 in co-immunoprecipitation
experiments is indirect and might be mediated by another
molecule [23,24]. A candidate for this mediator could be a
protein of the 14-3-3 family, because Ksr contains 14-3-3-
binding motifs similar to those of Raf proteins. It was
recently reported that 14-3-3ζ interacts with Ksr [24].
However, a Raf-phosphopeptide containing the 14-3-3-
binding motif was shown to inhibit 14-3-3 binding to Ksr,
but not the Raf-1–Ksr interaction, suggesting that the asso-
ciation of Raf-1 and Ksr is not mediated by 14-3-3 [24].
The data presented here suggest that another candidate
for mediating the Ksr–Raf interaction could be MEK.
Indeed, we have shown, using three different experi-
mental approaches, that MEK and Ksr can form com-
plexes. MEK could be co-immunoprecipitated with both
full-length mouse Ksr-1 overexpressed in COS-1 cells
and endogenous Ksr-1 in rat PC12 cells, suggesting that
this interaction takes place in vivo. We also found that
full-length mKsr-1 associated with MEK-1 in vitro, thus
confirming that the Ksr–MEK interaction is direct. This
interaction appears to be strong: it is detected in the
yeast two-hybrid system with an affinity comparable to
B-Raf–MEK and Raf-1–MEK interactions. In this
system, however, the full-length Ksr protein displayed a
much lower affinity for MEK than that observed with
the isolated kinase domain (growth in the absence of
histidine could be seen but there was no detectable β-
galactosidase activity for the full-length protein). This
may be because of incorrect folding of the full-length
protein, or because of a defect in its nuclear transport;
the recombinant protein is likely to exceed 120 kDa in
size when fused to Gal4. The observation that Ksr binds
MEK is compatible with the structural similarity that
Figure 5
Inhibition of Ras-induced NIH3T3 cell transformation by mKsr-1.
Plasmids encoding RasV12, RacV12, RhoV14, RalL72 and Ras
effector mutants (Ser35, Gly37 and Cys40 in a Val12 background)
were transfected into NIH 3T3 cells either alone (white bars) or in
combination with pSVL/mKsr-1 (gray bars). Note that only 5 ng of
RasV12 plasmid were used, compared to 0.5 µg for all other
constructs. Focus formation assays were carried out over two weeks.
Numbers represent at least two independent experiments.
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Figure 6
Inhibition by mKsr-1 of the proliferation of chicken neuroretina cells
induced by Ras and Raf but not that induced by MEK. Chicken
embryonic NR cell cultures were induced to proliferate upon infection
with C11, IC11 and RCAS/MEKDD avian retroviruses, which express 
v-Ha-Ras, v-Rmil and MEK-1DD, respectively. Exponentially growing
cultures were transfected with equal amounts of either pRcRSV/mKsr-1
or empty pRcRSV plasmids as indicated. After selection for neomycin-
resistant cells, foci of proliferating NR cells were stained with crystal
violet. The experiment was repeated three times with different NR
cultures and DNA preparations and produced essentially the same
results.
pRcRSV pRcRSV/ mKsr-1 Untransfected
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Ksr shares with Raf: Raf and Ksr proteins are more
closely related to each other than they are to other
kinases such as MEKK1 and Mos, both of which are also
able to phosphorylate and activate MEK-1, at least in
vitro [48,49]. 
These observations suggested that Ksr could act as a
MEK kinase, but we and others failed to detect direct
phosphorylation and activation of MEK by Ksr. On the
contrary, we observed that the kinase activity of MEK
was inhibited when MEK was bound to Ksr. We recently
observed that overexpression of mKsr-1 was not suffi-
cient to induce proliferation in primary cultures of avian
post-mitotic NR cells, although overexpression of Raf-1
and B-Raf was sufficient (C.P., A.D-G., D.L., G.C. and
A.E., unpublished observations). Similarly, transfected
mKsr-1 did not induce phenotypic changes in NIH3T3
cells (Figure 5), and furthermore, mKsr-1 significantly
decreased Ras-induced transformation in NIH3T3 cells,
a result consistent with the ability of mKsr-1 to block
MEK in an inactive state. This effect is likely to be
mediated through regulation of the MAP kinase pathway,
given that mKsr-1 expression did not reduce the transfor-
mation induced by other activated GTPases such as Rac
or Rho. In addition, the inability of mKsr-1 to cooperate
with Ras in transformation was confirmed by the fact that
mKsr-1 did not synergize with Ras effector mutants to
induce transformation. The inhibitory effect of mKsr-1
on the MAP kinase pathway in vivo is not restricted to
established fibroblasts; we found that overexpression of
mKsr-1 significantly inhibited Ras- and B-Raf-induced
chicken embryonic NR cell proliferation. In contrast,
overexpression of mKsr-1 was not sufficient to abolish
NR cell proliferation induced by a constitutively acti-
vated MEK-1 protein (MEKDD), in agreement with a
mechanism of action at the level of MEK. We observed a
slight decrease in the growth rate of these cells, however,
perhaps because MEKDD retains the capacity to interact
with Ksr (data not shown).
Thus, Ksr appears to act as an inhibitor rather than an acti-
vator of MEK in the biological assays used in this study. A
simplistic model would be that Ksr is a regulated attenua-
tor of the Ras–MAP kinase cascade in vivo, inhibiting the
pathway at the level of MEK (Figure 7a). However, this
model contradicts the results of previous studies suggest-
ing that Ksr positively regulates the Ras–MAP kinase
pathway. Alternative possible models could be proposed
to explain this apparent discrepancy: for example, Ksr may
be a MEK kinase, or may be a co-activator of MEK
(Figure 7b,c). We do not exclude the possibility that Ksr
could be a MEK kinase, although we failed to demon-
strate that mKsr-1 can activate MEK. Perhaps mKsr-1 is in
an inactive conformation in the cell systems used in this
study, thus preventing the phosphorylation, activation and
release of MEK. An objection to a model in which Ksr is a
MEK kinase is that if Ksr and Raf proteins compete for
the same substrate, they would not be expected to co-
localize, and it would remain to be determined why these
proteins are found in the same membrane-bound complex
[23,24]. Alternatively, mKsr-1 could be a MAP kinase
kinase kinase with a different substrate specificity from
Raf kinases. Because Ksr shares structural similarities with
Raf, Ksr, when overexpressed, could bind MEK in a non-
physiological manner, without phosphorylating it. This
possibility is unlikely, however, because endogenous Ksr
and MEK co-immunoprecipitated in PC12 cells, a strong
affinity was detected in the two-hybrid system, and
because there was no interaction between mKsr-1 and
other known MAP kinase kinases (MKK-3 and MKK-4).
Another possibility is that mKsr-1 is not a MEK kinase by
itself but rather serves as a co-activator by stabilizing the
Raf–MEK complex, or by presenting MEK to Raf for
phosphorylation and activation (Figure 7c). Although this
model does not explain why Raf and Ksr are structurally
similar, or the role of the putative kinase activity of Ksr, it
could nevertheless explain the interaction of Ksr with Raf
and why Ksr does not phosphorylate MEK. In this
hypothesis, an explanation for the ability of Ksr to inhibit
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Figure 7
Alternative models for Ksr function. (a) Ksr is
a regulated attenuator of the Ras–MAP kinase
cascade and acts by inhibiting the pathway at
the level of MEK. (b) Ksr is a MEK kinase
(MAP kinase kinase kinase). In the cell
systems used in this study, mKsr-1 is in an
inactive conformation thus preventing the
phosphorylation, activation and release of
MEK. The signal which activates the kinase
activity of Ksr remains to be characterized
(indicated by ?). (c) Ksr acts as a co-activator
of MEK by stabilizing the Raf–MEK complex
or by presenting MEK to Raf for
phosphorylation and activation. See text for
further details.
MEK
? ?
MEK
Ras Ras Ras
Ksr Raf Ksr Raf Ksr Raf
MEK
(a) (b) (c)
Current Biology
Ras signaling that was observed in both NIH3T3 and NR
cells could be either that the cells lack a signal required to
activate Ksr or that the overexpression of Ksr could titrate
MEK and sequester it out of the Ras–Raf complex,
thereby preventing its activation.
Some of these models imply that Ksr must be activated
before it can regulate MEK activation, and that the
pathway activating Ksr was not stimulated in the
conditions used in this study. Interestingly, several lines of
evidence suggest that Ksr and Raf proteins are differen-
tially regulated. First, it appears clear from our results that
mKsr-1 is not regulated by Ras, as Raf is. Second, the
kinase domain of Raf proteins can be constitutively acti-
vated by truncation of the amino terminus of the proteins,
whereas similar deletions in Ksr produced constitutive
dominant-negative effects on the Ras–MAP kinase cascade
in both the Drosophila Sevenless and Xenopus oocyte matu-
ration pathways [23]. That the amino terminus of mKsr-1 is
required for its activity is also suggested by the identifica-
tion of a loss-of-function mutation located in the CA1
domain of Drosophila Ksr [20]. We have not yet identified
any stimulus that can activate Ksr. Zhang et al. [25] have
reported that Ksr is activated by ceramide in vitro,
however, and by factors, such as TNFα, which increase
ceramide levels in cells. In addition, they found that Ksr
complexes with, phosphorylates and activates Raf-1 in vitro
and in vivo. We have not detected activation of Ksr by
ceramide or activation of Raf-1 by Ksr. The reasons for this
discrepancy are at present unclear. It is noteworthy that
Ksr loss-of-function mutations have no effect by them-
selves on Drosophila Sevenless and C. elegans vulval induc-
tion pathways in otherwise wild-type animals, suggesting
that Ksr is dispensable for these terminal differentiation
pathways. In contrast, these mutations induce embryonic
lethality in the same hosts suggesting an important role for
Ksr in early development. Interestingly, the biological
system in which mammalian Ksr-1 was shown to cooperate
with activated Ras is the maturation of the Xenopus oocyte.
It is therefore conceivable that the components of the sig-
naling pathway activating Ksr are absent or repressed in
the differentiated cell types used in this study. 
Conclusions
We provide evidence that, like Raf proteins, the kinase
supressor of Ras (Ksr) interacts directly with the MAP
kinase kinase MEK. Overexpression of mKsr-1 inhibits
both Ras-induced transformation of established fibroblasts
and the proliferation of chicken embryonic neuroretina
cells induced by Ras or B-Raf. Overexpression of mKsr-1
is not sufficient to abolish cell proliferation induced by a
constitutively activated MEK-1 protein, however. Taken
together, our results suggest a role for Ksr in regulating the
MAP kinase pathway at least in part through its ability to
form a complex with MEK, and the results raise the possi-
bility of a previously unidentified function for Ksr. 
Materials and methods
Cell cultures
COS-1 cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% newborn calf serum [50]. Transfections of
these cells were carried out using the DEAE–Dextran method [50]. For
serum stimulation, COS-1 cells were starved overnight in DMEM con-
taining 0.4% BSA and treated with 20% newborn calf serum for
10 min. PC12 cells were cultured in DMEM containing 10% horse
serum and 5% fetal calf serum. For growth factor stimulation, cultures
at 80% confluency were serum starved overnight in 0.4% serum and
stimulated with EGF (Calbiochem) at 50 ng/ml for 2 min, or NGF
(Boehringer Mannheim) at 50 ng/ml for 5 min. NIH3T3 cells were cul-
tured in DMEM containing 10% newborn calf serum. Neuroretina (NR)
cell cultures were prepared from 8 day-old Brown Leghorn chicken
embryos [51]. Cultures were maintained and passaged in Eagle basal
medium supplemented with 8% fetal calf serum. Viral stocks of avian
retroviruses were used to infect NR cultures: IC11 virus contains the
v-Rmil oncogene, an activated version of the avian homolog of B-Raf
[43], and C11 virus (kindly provided by Thomas Graf) contains the
v-Ha-Ras oncogene [44]. 
Plasmid constructions and anti-mKsr-1 serum preparation
Different portions of the murine Ksr-1 cDNA (kindly provided by Gerald
Rubin) were inserted into two-hybrid vectors in-frame with either
sequences encoding the Gal4 DNA-binding domain (pGBT9), or
sequences encoding the Gal4 transcriptional activation domain
(pGADGH). Fusions with full-length mKsr-1 were obtained by sub-
cloning the 4 kb EcoRI Ksr fragment from pMA57. The Ksr∆CA1 con-
struct contains the XhoI fragment encoding the mKsr-1 amino-acid
sequence from Arg187 to the stop codon. The KsrCA5 construct con-
tains the ApaI fragment encoding the mKsr-1 amino-acid sequence
from Gly540 to the stop codon. The reading frames of each fusion con-
struct between GAL4 and Ksr sequences was verified by sequencing.
The other constructs encoding fusion proteins with either Raf-1, B-Raf,
Ha-RasV12, MEK-1 or MEK-2 have been described previously [32].
The pSVL/mKsr-1 expression vector was obtained by subcloning the
SpeI–XbaI fragment (including the mKsr-1 EcoRI fragment) from
pGAD-GH/mKsr-1 into the XbaI cloning site of pSVL (Pharmacia). The
pRcRSV/mKsr-1 expression vector was generated by subcloning the
SpeI–XbaI fragment from pGAD-GH/mKsr-1 into the SpeI and XbaI
cloning sites of pRcRSV vector (Invitrogen), which contains the
neomycin-resistance gene. Constructs expressing activated versions of
Ras (pSG5/RasV12), Rac (pEXV3/RacV12), Rho (pEXV3/RhoV14),
Ral (pMT2/RalL72), as well as Ras effector mutants in a V12 back-
ground (Ser35, Gly37 and Cys40), have been described elsewhere
[28]. The pECE/HA-MEK-1 plasmid encoding the hemagglutinin (HA1)
epitope-tagged MEK-1 protein was kindly provided by Jacques
Pouysségur [52]. The RCAS/MEKDD virus was obtained as follows: the
cDNA encoding MEKDD [45] was cloned into the HindIII and SacI
cloning sites of the CLA12 adaptor plasmid [53] in order to flank the
cDNA by ClaI sites. The resulting ClaI fragment was then cloned into
the unique ClaI site of the RCAS-A retroviral vector [53]. A rabbit poly-
clonal antibody was raised against a peptide corresponding to the
carboxy-terminal sequence of mKsr-1: RFERFGLGTLESGNPKM (in
single-letter amino-acid code). This antibody was then affinity purified
over a peptide column.
Yeast two-hybrid system
Yeast cultures were grown as described previously [32]. The
Saccharomyces cerevisiae strain Hf7c [54] was co-transformed with
the different pGBT9- and pGADGH-derived constructs by the lithium
acetate method [55]. Co-transformants were plated on solid SC
medium lacking tryptophan, leucine and histidine to select for growth in
the absence of histidine. Qualitative determination of β-galactosidase
activity was performed on colonies patched on SC–Trp–Leu– plates by
a filter assay using 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal)
as substrate, essentially as previously described [56]. The strength of
the interaction between both proteins was tested in the two opposite
orientations and assessed by both HIS3 and lacZ expression [32].
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In vitro binding experiments
The 4 kb EcoRI Ksr fragment encoding the full-length mKsr-1 was sub-
cloned into the Bluescript pBKS(–) vector (Stratagene) and in vitro
T7-driven transcription and translation was performed in micrococcal
reticulocyte lysates using the TNT-coupled transcription/translation kit
(Promega) with [35S]methionine as the radioactive tracer amino acid in
a final volume of 50 µl. For binding experiments, 20 µl of the reaction
was incubated overnight at 4°C with 10 µg of immobilized GST alone
or GST–MEK-1 fusion protein (Upstate Biotechnology) in the presence
of 0.1 mM AEBSF (Interchim). After centrifugation, the supernatant
containing the unbound fraction was removed and the beads were
washed five times with buffer containing 0.2% Triton X-100, 10 mM
Tris pH 8.0, 150 mM NaCl and 2 mM EDTA. The bound proteins were
then eluted by boiling in gel sample buffer, resolved by SDS–PAGE
and transferred to Immobilon-P membranes (Millipore). Membranes
were autoradiographed before western blotting.
Immunoprecipitations from COS-1 cells
COS-1 cells were transfected, and lysed 48 h later in Triton X-100
lysis buffer [50]. Cell lysates were incubated with either the anti-mKsr-1
antibody at a 1:350 dilution, a rabbit antibody directed against an
amino-terminal peptide of MEK-1 (a gift of Jacques Pouysségur [52]) at
a 1:500 dilution, or the anti-HA-epitope 12CA5 monoclonal antibody
(Boehringer Mannheim) at a 1:330 dilution, and coupled to 50 µl of
pansorbin (Calbiochem) for 2 h. Immune complexes were washed
under stringent conditions [50] and either directly resolved by
SDS–PAGE for subsequent western blotting analysis or first subjected
to an in vitro kinase assay. For in vitro kinase assays, immune com-
plexes were washed once with kinase buffer (20 mM Hepes pH 7.2,
10 mM MgCl2, 10 mM MnCl2) and then incubated in the kinase buffer
containing 10 µCi of [γ-32P]ATP (3000 Ci/mmole; Amersham) for 30
min at 30°C in a final volume of 50 µl. Reactions were stopped with 2×
Laemmli sample buffer, resolved by SDS–PAGE and transferred to
Immobilon-P membranes. Membranes were autoradiographed before
western blotting. For immunoblot (western) analysis, membranes were
probed with either the anti-mKsr-1, the anti-HA-epitope or the anti-
MEK-1 antibody at a 1:2000 dilution and visualized by chemilumines-
cence as recommended by the manufacturer (Amersham). For
successive probing with different antibodies, membranes were
stripped in 62.5 mM Tris–HCl pH 6.7, 2% SDS and 100 mM
β-mercaptoethanol, at 50°C for 30 min.
Immunoprecipitations from PC12 cells
PC12 cells which had been stimulated with EGF (2 min) or NGF (5 min)
were harvested in 1 ml of lysis buffer (containing 50 mM Hepes,
100 mM NaCl, 1 mM EGTA, 1% Triton X-100, 2 mM NaF, 2 mM Na
pyrophosphate, 0.5 mM sodium orthovanadate, 0.1 mg/ml phenylmethyl-
sulfonylfluoride, 1 mM para-nitrophenylphosphate, and 10 mg/ml each of
leupeptin, pepstatin and aprotinin) and the lysates cleared for 15 min at
15,000 rpm. For co-precipitation, the lysates were immunoprecipitated
with either a MEK-1/2 polyclonal antibody (Transduction Laboratories;
1:250 dilution), the mKsr-1 polyclonal antibody (1:250 dilution) or the
Ksr pre-immune serum (1:250 dilution), in the presence or absence of
the immunizing Ksr peptide (10 µM). Immunoprecipitations were carried
out for 60 min at 4°C followed by a 30 min incubation with protein-
G–Sepharose (Sigma; 40 µl of a 1:1 slurry). Immunoprecipitates were
then washed three times in PBS–0.1% Triton X-100, resolved by 10%
SDS–PAGE and transferred to nitrocellulose. Immune complexes were
probed for the presence of Ksr and MEK using the Ksr-1 polyclonal anti-
body at a 1:1000 dilution, or a mix of the monoclonal MEK-1 (1:1000)
and MEK-2 (1:2500) antibodies (Transduction Laboratories). For the in
vitro kinase assays, immunoprecipitates were washed three times in
PBS–0.1% Triton X-100 followed by two washes in the kinase buffer
(25 mM Hepes pH 8.0, 10 mM MgCl2, 2 mM MnCl2). The kinase assay
was carried out in a final volume of 25 µl with 5 µCi of [γ-32P]ATP per
reaction, for 30 min at room temperature. Reactions were stopped with
Laemmli sample buffer, resolved by 10% SDS–PAGE and transferred to
nitrocellulose. Membranes were autoradiographed before western blot-
ting with anti-Ksr and anti-MEK antibodies as described above.
Transformation assays in NIH3T3 cells
Transformation assays were performed essentially as described previ-
ously [28]. Briefly, low passage NIH3T3 cells were seeded at
1.5 × 105 per well in six-well dishes the day before lipofection (lipofect-
AMINE reagent from Gibco-BRL) with 0.5 µg of each plasmid (apart
from pEXV3/RasV12 for which only 5 ng were used). Two days later,
the cells were transferred to 10 cm dishes. After reaching confluence,
the dishes were kept in DMEM containing 5% calf serum for two
weeks, after which they were stained with 1.0% crystal violet (in 20%
ethanol) to visualize foci.
NR cell transfections
NR cultures induced to proliferate upon infection with C11, IC11 and
RCAS/MEKDD viruses were transfected by the calcium phosphate
method [57]. One day before transfection, proliferating NR cultures
were seeded at 106 cells per 100 mm dish. Cells were then trans-
fected with equal amounts of either pRcRSV/mKsr-1 or empty pRcRSV
plasmids (varying the amount of DNA between 1 and 10 µg gave rise
to comparable results) and G418 selection was applied 7 days later for
7 days. Cells were then rinsed with PBS, and foci of proliferating NR
cells were stained with 1.0% crystal violet (in 20% ethanol).
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